Ignite Creation Date:
2025-12-17 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 1:34 AM
Study NCT ID:
NCT00813358
Status:
COMPLETED
Last Update Posted:
2021-06-04
First Post:
2008-12-19
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Zenith TX2® Post-market Approval Study
Sponsor:
Cook Research Incorporated
Organization:
Study Overview
Official Title:
Zenith TX2® TAA Endovascular Graft Post-approval Study
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TX2 2PAS
Brief Summary:
The Zenith TX2® Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2® TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 370024, 2PAS | None | None | View |